articleTop 1% cited
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
The Lancet · 2002 · Vol. 359(9311) · pp. 995–1003
Björn Dahlöf✉(Sahlgrenska University Hospital)Richard B. Devereux(NewYork–Presbyterian Hospital)Sverre E. Kjeldsen(Oslo University Hospital)Stevo Julius(University of Michigan–Ann Arbor)Gareth Beevers(Birmingham City Hospital)Ulf dé Fairé(Karolinska University Hospital)Frej Fyhrquist(Helsinki University Hospital)Hans Ibsen(Glostrup Hospital)Krister Kristiansson(MSD (Sweden))Ole Lederballe‐Pedersen(Regionshospitalet Viborg)Lars Lindholm(Umeå University)Markku S. Nieminen(Helsinki University Hospital)Per Omvik(Haukeland University Hospital)Suzanne Oparil(University of Alabama at Birmingham)Hans Wedel(Nordic School of Public Health)
Blood Pressure and Hypertension StudiesHormonal Regulation and HypertensionRenin-Angiotensin System StudiesAtenololMedicineLosartanBlood pressureMyocardial infarctionStroke (engine)CardiologyInternal medicineLeft ventricular hypertrophyClinical endpoint
Citations
5,407
FWCI
296.50
field-weighted impact
References
29
Percentile
100%
vs. same field & year
Citations per year
Cited by
2018 ESC/ESH Guidelines for the management of arterial hypertension
European Heart Journal · 2018 · 10,258 citations
Pleiotropic AT1 Receptor Signaling Pathways Mediating Physiological and Pathogenic Actions of Angiotensin II
Molecular Endocrinology · 2005 · 530 citations
2018 ESC/ESH Guidelines for the management of arterial hypertension
Journal of Hypertension · 2018 · 2,790 citations
Blood pressure-dependent and independent effects of agents that inhibit the renin–angiotensin system
Journal of Hypertension · 2007 · 411 citations
2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension
Journal of Hypertension · 2003 · 2,689 citations
Minireview: Adiposity, Inflammation, and Atherogenesis
Endocrinology · 2003 · 756 citations
Is Oxidative Stress the Pathogenic Mechanism Underlying Insulin Resistance, Diabetes, and Cardiovascular Disease? The Common Soil Hypothesis Revisited
Arteriosclerosis Thrombosis and Vascular Biology · 2004 · 1,368 citations
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
JAMA · 2013 · 7,939 citations
References
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
New England Journal of Medicine · 2000 · 8,641 citations
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
New England Journal of Medicine · 2001 · 7,433 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.